Evidence map›Paper›PMID 31704785›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2020

A Mutation in

Qiu T Ruan, Neema Yazdani, Benjamin C Blum, Jacob A Beierle, Weiwei Lin, Michal A Coelho, Elissa K Fultz, Aidan F Healy, John R Shahin, Amarpreet K Kandola and 14 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Qiu T RuanBiomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Neema YazdaniBiomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Benjamin C BlumCenter for Network Systems Biology, Boston University School of Medicine, Boston, Massachusetts 02118.
Jacob A BeierleBiomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Weiwei LinCenter for Network Systems Biology, Boston University School of Medicine, Boston, Massachusetts 02118.
Michal A CoelhoDepartment of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
Elissa K FultzDepartment of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
Aidan F HealyDepartment of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
John R ShahinDepartment of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
Amarpreet K KandolaLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Kimberly P LuttikLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Karen ZhengLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Nathaniel J SmithLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Justin CheungLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.
Farzad MortazaviDepartment of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts 02118.
Daniel J ApiccoLaboratory of Neurodegeneration, Department of Pharmacology and Experimental Therapeutics and Neurology, Boston University School of Medicine, Boston, Massachusetts 02118.
Durairaj Ragu VarmanDepartment of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, Virginia 23284, and.
Sammanda RamamoorthyDepartment of Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, Virginia 23284, and.
Peter E A AshLaboratory of Neurodegeneration, Department of Pharmacology and Experimental Therapeutics and Neurology, Boston University School of Medicine, Boston, Massachusetts 02118.
Douglas L RoseneDepartment of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts 02118.
Andrew EmiliCenter for Network Systems Biology, Boston University School of Medicine, Boston, Massachusetts 02118.
Benjamin WolozinLaboratory of Neurodegeneration, Department of Pharmacology and Experimental Therapeutics and Neurology, Boston University School of Medicine, Boston, Massachusetts 02118.ORCID 0000-0003-2068-1475
Karen K SzumlinskiDepartment of Psychological and Brain Sciences, University of California, Santa Barbara, California 93106.
Camron D BryantBiomolecular Pharmacology Training Program, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118, camron@bu.edu.ORCID 0000-0003-4505-5809
Boston University · USUniversity of California, Santa Barbara · USVirginia Commonwealth University · US

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in miceR01DA039168 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2015 to 2019
$3.0M
Genetic Basis of Opioid Reward and Aversion in MiceR00DA029635 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2013 to 2016
$750k
QUANTSTUDIO 12K FLEX OPEN ARRAY REAL-TIME PCR SYSTEMS10OD023663 · OD · BOSTON MEDICAL CENTER · PI DENG, LINGYI L · 2017 to 2017
$186k
Functional mechanisms of Hnrnph1 in methamphetamine addictive behaviorsF31DA040324 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI YAZDANI, NEEMA · 2016 to 2017
$49k
NIDA NIH HHS F31 DA040324NIDA NIH HHS R00 DA029635NIDA NIH HHS R01 DA039168NIGMS NIH HHS T32 GM008541NIH HHS S10 OD023663
6 · The paper itself

Abstract

Individual variation in the addiction liability of amphetamines has a heritable genetic component. We previously identified

Indexed as

Reinforcement, PsychologyRewardAnimalsAnxietyCorpus StriatumDopamineDopaminergic NeuronsExonsExploratory BehaviorFemaleHeterogeneous-Nuclear Ribonucleoprotein Group F-HHeterogeneous-Nuclear RibonucleoproteinsHeterozygoteMaleMesencephalonMethamphetamineDopamineHeterogeneous-Nuclear Ribonucleoprotein Group F-HHeterogeneous-Nuclear RibonucleoproteinsHnrnph1 protein, mouseMethamphetamineMitochondrial ProteinsaddictionHnrnph1methamphetaminemitochondriapsychostimulantsRNA binding protein

Identifiers

PMID31704785
PMCPMC6939476
OpenAlexW2986143808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.